Brain Advance Access published online on February 13, 2006
Brain, doi:10.1093/brain/awl031
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Division of Neurology and Toronto Western Research Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada; Dipartimento di Neuroscienze, Scienze Psichiatriche ed Anestesiologiche, Universita' di Messina, Messina, Italy
* To whom correspondence should be addressed. Experimental models of Parkinson's disease have demonstrated abnormal synaptic plasticity in the corticostriatal system, possibly related to the development of levodopa-induced dyskinesias (LID). We tested the hypothesis that LID in Parkinson's disease is associated with aberrant plasticity in the human motor cortex (M1). We employed the paired associative stimulation (PAS) protocol, an experimental intervention involving transcranial magnetic stimulation (TMS) and median nerve stimulation capable of producing long-term potentiation (LTP) like changes in the sensorimotor system in humans. We studied the more affected side of 16 moderately affected patients with Parkinson's disease (9 dyskinetic, 7 non-dyskinetic) and the dominant side of 9 age-matched healthy controls. Motor-evoked potential (MEP) amplitudes and cortical silent period (CSP) duration were measured at baseline before PAS and for up to 60 min (T0, T30 and T60) after PAS in abductor pollicis brevis (APB) and abductor digiti minimi (ADM) muscles. PAS significantly increased MEP size in controls (+74.8% of baseline at T30) but not in patients off medication (T30: +0.07% of baseline in the non-dyskinetic, +27% in the dyskinetic group). Levodopa restored the potentiation of MEP amplitudes by PAS in the non-dyskinetic group (T30: +64.9% of baseline MEP) but not in the dyskinetic group (T30: -9.2% of baseline). PAS prolonged CSP duration in controls. There was a trend towards prolongation of CSP in the non-dyskinetic group off medications but not in the dyskinetic group. Levodopa did not restore CSP prolongation by PAS in the dyskinetic group. Our findings suggest that LTP-like plasticity is deficient in Parkinson's disease off medications and is restored by levodopa in non-dyskinetic but not in dyskinetic patients. Abnormal synaptic plasticity in the motor cortex may play a role in the development of LID.
Received July 26, 2005
Revised January 7, 2006
Accepted January 14, 2006
Article
Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias
Francesca Morgante 1,
Alberto J. Espay 2,
Carolyn Gunraj 2,
Anthony E. Lang 2,
and
Robert Chen 2 *
2 Division of Neurology and Toronto Western Research Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada
Robert Chen, E-mail: robert.chen{at}uhn.on.ca
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  V. Di Lazzaro, M. Dileone, F. Pilato, P. Profice, A. Oliviero, P. Mazzone, A. Insola, F. Capone, F. Ranieri, and P.A. Tonali Associative Motor Cortex Plasticity: Direct Evidence in Humans Cereb Cortex, October 1, 2009; 19(10): 2326 - 2330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Chu, A. Wagle-Shukla, C. Gunraj, A. E. Lang, and R. Chen Impaired presynaptic inhibition in the motor cortex in Parkinson disease Neurology, March 3, 2009; 72(9): 842 - 849. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Foltynie, B Cheeran, C H Williams-Gray, M J Edwards, S A Schneider, D Weinberger, J C Rothwell, R A Barker, and K P Bhatia BDNF val66met influences time to onset of levodopa induced dyskinesia in Parkinson's disease J. Neurol. Neurosurg. Psychiatry, February 1, 2009; 80(2): 141 - 144. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. A. Prescott, J. O. Dostrovsky, E. Moro, M. Hodaie, A. M. Lozano, and W. D. Hutchison Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients Brain, February 1, 2009; 132(2): 309 - 318. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Calabresi, N. B. Mercuri, and M. Di Filippo Synaptic plasticity, dopamine and Parkinson's disease: one step ahead Brain, February 1, 2009; 132(2): 285 - 287. [Full Text] [PDF]
|
|
|
|
 |
|
 V. Di Lazzaro, F. Pilato, M. Dileone, P. Profice, A. Oliviero, P. Mazzone, A. Insola, F. Ranieri, P. A. Tonali, and J. C. Rothwell Low-frequency repetitive transcranial magnetic stimulation suppresses specific excitatory circuits in the human motor cortex J. Physiol., September 15, 2008; 586(18): 4481 - 4487. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Quartarone, F Morgante, A Sant'Angelo, V Rizzo, S Bagnato, C Terranova, H R Siebner, A Berardelli, and P Girlanda Abnormal plasticity of sensorimotor circuits extends beyond the affected body part in focal dystonia J. Neurol. Neurosurg. Psychiatry, September 1, 2008; 79(9): 985 - 990. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. V. Sale, M. C. Ridding, and M. A. Nordstrom Cortisol Inhibits Neuroplasticity Induction in Human Motor Cortex J. Neurosci., August 13, 2008; 28(33): 8285 - 8293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. V. Frantseva, P. B. Fitzgerald, R. Chen, B. Moller, M. Daigle, and Z. J. Daskalakis Evidence for Impaired Long-Term Potentiation in Schizophrenia and Its Relationship to Motor Skill Leaning Cereb Cortex, May 1, 2008; 18(5): 990 - 996. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Meunier, H. Russmann, M. Simonetta-Moreau, and M. Hallett Changes in Spinal Excitability After PAS J Neurophysiol, April 1, 2007; 97(4): 3131 - 3135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sailer, D. I. Cunic, G. O. Paradiso, C. A. Gunraj, A. Wagle-Shukla, E. Moro, A. M. Lozano, A. E. Lang, and R. Chen Subthalamic nucleus stimulation modulates afferent inhibition in Parkinson disease Neurology, January 30, 2007; 68(5): 356 - 363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Weise, A. Schramm, K. Stefan, A. Wolters, K. Reiners, M. Naumann, and J. Classen The two sides of associative plasticity in writer's cramp Brain, October 1, 2006; 129(10): 2709 - 2721. [Abstract] [Full Text] [PDF]
|
|